Moteur de recherche d’entreprises européennes
Financement britannique (744 546 £) : STEP - Technologie évolutive pour l’extraction de produits pharmaceutiques Ukri 01/09/2009 Recherche et innovation du Royaume-Uni, Royaume Uni
Vue d’ensemble
Texte
STEP - Technologie évolutive pour l’extraction de produits pharmaceutiques
| Abstract | The aim of the project is to drive substantial cost efficiency in both drug development and drug manufacturing processes by developing commercial counter current separation technology which will allow selective purifications to be achieved at a loading of approximately 1kg/day. In contrast to high-performance liquid chromatography, counter current separations do not require expensive packing materials; are more tolerant of particulate matter and have the benefit of excellent reproducibility. The project will demonstrate the broad applicability of the technology to pharmaceutical separation problems and specific examples will be more closely examined demonstrating separation capability at scale. |
| Category | Collaborative R&D |
| Reference | 100733 |
| Status | Closed |
| Funded period start | 01/09/2009 |
| Funded period end | 31/08/2012 |
| Funded value | £744 546,00 |
| Source | https://gtr.ukri.org/projects?ref=100733 |
Participating Organisations
| GLAXOSMITHKLINE PLC |
£67 920,00 |
| BRUNEL UNIVERSITY LONDON |
£396 719,00 |
| PFIZER LIMITED |
£1 000,00 |
| DYNAMIC EXTRACTIONS LIMITED |
£278 907,00 |
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : GSK plc, Londres, Royaume Uni.